top of page

About Us

VUZE Medical was incorporated in 2017 in Israel and is financed privately.  Milestones so far include high accuracy and speed on an anatomical model (2018) and in cadaver surgeries (2019-2020), a first US Patent (2020, with five more since), first European and Asian patents (2021), FDA 510(k) submission (2021), successful first-in-human surgery (late 2021), FDA 510(k) clearance for minimally-invasive thoracolumbar fixation and augmentation  (2022), the completion of a highly-successful twenty-patient clinical trial (early 2023) and cadaveric proofs of concept  for pain therapy and open surgery (mid 2023).


Extensive Experience and a Strong Track Record

A veteran team brings strong domain expertise in adding computer guidance to common manual interventions. Our two prior endeavors have each become a Standard of Care in its respective field: superDimension (now Medtronic) in bronchoscopies with 1,000 installations worldwide, and SyncVision (now Philips) in coronary catheterizations with 4,000 installations worldwide.


left to right:
Sasha Steinberg  algorithms
Sigi Elazar  UI & UX
Rivay Mor  algorithms
Koby Zakaeim  application engineering
Neta Stern  software
Yoav Stein  ​software
Levona Schriger  testing & support
Asaf Omer  QA & RA 
Ran Cohen  CTO
David Tolkowsky  CEO


VUZE Medical Ltd.

13 Zarhin St., Entrance A, Floor 7
Ra’anana 4366241, Israel 

Copyright © 2023 VUZE Medical Ltd. All rights reserved. Proprietary. Patents granted. Patents pending. The VUZE system, VUZE software and Dynamic Online Image Registration (DOLIR) are trademarks of VUZE Medical.

bottom of page